Company profile
BioSynaptica company profile
Targeting Neurodegeneration with Engineered Erythropoietin. BioSynaptica is a biotech startup pioneering the development of innovative biotherapeutics derived from human erythropoietin (hEPO) for the treatment of neurodegenerative disorders, with a focus on retinal diseases.
Business identity
- Website
- https://biosynaptica.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2020-07-24
Headquarters
- Headquarters
- Santa Fe, Santa Fe, Argentina
- Postal code
- 3000
- Country code
- AR
- Continent
- South America